Interviews

Aaron Lyss on What the Next Oncology Payment Model Should Include
June 11, 2020 – 
Benchmarking, accountability, bilateralism, and scalability are the 4 parameters critical to successful alternative payment models in oncology, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.
Dr Stewart Factor on Implications, Treatment of OFF Periods in Parkinson Disease
June 08, 2020 – 
There are a growing number of innovations within treatment of OFF periods in Parkinson disease that seek to address this unmet need in patient care, said Stewart Factor, DO, professor of Neurology and director of the Movement Disorders Program at the Emory University School of Medicine.
Aaron Lyss Outlines Lessons Learned From Data Analytics
June 06, 2020 – 
In each performance period of the Oncology Care Model for which we've received data, we've seen different aspects of care that we can improve upon in the following 6 months, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.
Lili Brillstein Discusses Incorporating Social Determinants of Health Into Value-Based Care
June 05, 2020 – 
Unlike in fee-for-service, we have an amazing opportunity to begin to understand and build in factors that will keep patients healthy and give them the best outcomes possible, said Lili Brillstein, CEO of Brillstein Collaborative Consulting, and former Director for Episodes of Care at Horizon Blue Cross Blue Shield of New Jersey.
Aaron Lyss Discusses Practice Transformation Under the OCM
May 30, 2020 – 
The Oncology Care Model (OCM) has helped practices develop their capacity to use data for continuous quality improvement, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.
Lili Brillstein on Mandatory, Voluntary Payment Models
May 29, 2020 – 
There will never be all mandatory payment models or all value-based models, but we can craft a value-based model around just about anything as long as everybody agrees on what the criteria is, said Lili Brillstein, CEO of Brillstein Collaborative Consulting, and former Director for Episodes of Care at Horizon Blue Cross Blue Shield of New Jersey.
Dr James Wheless on Implications, Strategies of Managing Epilepsy Amid COVID-19
May 28, 2020 – 
Forming an action plan to manage treatment of patients with epilepsy, as well as factors such as stress and anxiety that may be intensified amid the COVID-19 pandemic, can assist in lessening the uptick of seizures and emergency department use, said James Wheless, MD, director of the Le Bonheur Comprehensive Epilepsy Program and chief of the Department of Pediatric Neurology at the University of Tennessee Health Science Center.
Elizabeth Colyer on State Level Takeaways From Sharecare's Flatten the Curve Survey
May 26, 2020 – 
From a state-level perspective, Sharecare's Flatten the Curve survey highlights the negative impact of COVID-19 on respondents in states with typically high mental, financial well-being, as well as the lack of change in those within states already known for these negative tendencies, said Elizabeth Colyer, senior vice president of Community Well-Being Index at Sharecare.
Elizabeth Colyer Discusses Nationwide Takeaways From Sharecare's Flatten the Curve Survey
May 22, 2020 – 
Based on the respondent pool, Sharecare observed 3 core takeaways from the Flatten the Curve survey–mental well-being, the connection between health and wealth, and access to health care, said Elizabeth Colyer, senior vice president of Community Well-Being Index at Sharecare.
Lili Brillstein Outlines Challenges of Incorporating Value-Based Care in Oncology
May 18, 2020 – 
New technologies and quick drug approvals contribute to the challenges of incorporating value-based care in oncology, said Lili Brillstein, CEO of Brillstein Collaborative Consulting, and former Director for Episodes of Care at Horizon Blue Cross Blue Shield of New Jersey.
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.